Evidence Snapshot

Glutamate NMDA receptor

CHEMBL1907608 PROTEIN COMPLEX GROUP Rattus norvegicus

Source Header

ChEMBL 36 via Core Engine

Target Snapshot 2026-09-13T20:45:25Z

Source · ChEMBL 36 via Core Engine Freshness · Sep 14, 2026, 5:45 AM KST As of · Sep 13, 2026

ChEMBL ChEMBL 36 CHEMBL1907608

Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Glutamate NMDA receptor as ChEMBL target CHEMBL1907608, mapped to UniProt P35439. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor

Glutamate NMDA receptor

PROTEIN COMPLEX GROUP · Rattus norvegicus

As of 2026-09-13

ChEMBL target ID

CHEMBL1907608

Primary anchor for compounds, assays, approvals, and exports

ChEMBL 36 via Core Engine As of 2026-09-13

www.ebi.ac.uk

UniProt accession

P35439

Glutamate receptor ionotropic, NMDA 1

UniProt accession via ChEMBL component mapping As of 2026-09-13

www.uniprot.org

Disease evidence contract

Open Targets-ready proxy

ChEMBL drug mechanism + indication proxy

ChEMBL drug mechanism + indication proxy As of 2026-09-13

www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Review-ready Target Rationale

Why Glutamate NMDA receptor matters

As of 2026-09-13

Glutamate NMDA receptor is reviewed as Glutamate receptor ionotropic, NMDA 1 (UniProt P35439); the current evidence base includes 22 approved drugs, 3932 compounds, and 839 assays, with lead potency reaching pChEMBL 9.5.

Protein context

Glutamate receptor ionotropic, NMDA 1

Glutamate receptor ionotropic, NMDA 1 Sequence length is 938 aa.

Review this target as Glutamate NMDA receptor, mapped to UniProt P35439. ChEMBL maps the protein component as Glutamate receptor ionotropic, NMDA 1. Sequence length is 938 aa.

Protein source · UniProt accession via ChEMBL component mapping

UniProt P35439 Protein

Disease context

Disease signal

Disease relevance is not yet populated for this evidence card.

This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.

ChEMBL target record

Activity base

Portfolio and assay base

ChEMBL currently tracks 22 approved drugs, 3932 compounds, and 839 assays for this target. The dominant activity type is IC50. CHEMBL540084 is the current potency anchor at pChEMBL 9.5.

Use CHEMBL540084 as the tractability anchor when discussing potency (pChEMBL 9.5).

Activity source · ChEMBL 36 via Core Engine

22 approved pChEMBL 9.5

Source Guidance

Start with the right source

Pick the first block or linked source that matches the review question in front of you.

Need the shortest review narrative first?

Review-ready Target Rationale

One-page rationale with as-of-date and attribution

Start with the review rationale when you need to explain why Glutamate NMDA receptor matters before drilling into raw source blocks.

Jump to Review Rationale

Need stable protein naming or accession mapping?

UniProt Target Context

UniProt accession via ChEMBL component mapping

Go back to the target snapshot when you need the naming and mapping contract behind UniProt P35439, not just the summarized rationale.

Open Protein Context

Need disease fit or evidence level for program framing?

Disease Relevance & Evidence Level

ChEMBL drug mechanism + indication proxy

Use the target snapshot disease block when you need the disease program and supporting signals, not only the card summary.

Open Disease Context

Snapshot State

No project snapshot selected. Export uses the live evidence card state.

3932

Total Compounds

839

Total Assays

Approved Drugs

IC50: 2943.0, KI: 1663.0, EC50: 56.0, KD: 13.0

Activity Types

pChEMBL Activity Distribution

Top 5 Inhibitors (by pChEMBL)

Compound	pChEMBL	Type	Phase
No preferred name CHEMBL540084	9.5	IC50	—
No preferred name CHEMBL299281	9.1	IC50	—
No preferred name CHEMBL39881	9.0	Ki	—
No preferred name CHEMBL197208	9.0	Ki	—
No preferred name CHEMBL59894	9.0	IC50	—